AbbVie (ABBV) EBT (2012 - 2026)
AbbVie (ABBV) posted quarterly EBT of $1.0 billion for Q1 2026, down 37.45% year-over-year from $1.7 billion in Q1 2025, and down 61.06% quarter-over-quarter from $2.7 billion in Q4 2025.
AbbVie (ABBV) EBT (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported EBT for 15 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 37.45% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $6.0 billion (up 64.96% YoY), while the FY2025 annual figure was $6.6 billion, up 77.53% from the prior year.
- EBT slipped to $1.0 billion in Q1 2026 per ABBV's latest filing, from $2.7 billion in the prior quarter.
- Across five years, EBT topped out at $4.9 billion in Q1 2022 and bottomed at -$2.3 billion in Q4 2024.
- Historically, EBT has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2024.
- On a YoY basis, EBT climbed as much as 269.47% in 2024 and fell as far as 287.21% in 2024.
- AbbVie's EBT stood at $3.0 billion in 2022, then plunged by 59.12% to $1.2 billion in 2023, then sank by 287.21% to -$2.3 billion in 2024, then jumped by 217.58% to $2.7 billion in 2025, then plunged by 61.06% to $1.0 billion in 2026.
- Business Quant data shows ABBV's EBT at $1.0 billion in Q1 2026, $2.7 billion in Q4 2025, and $714.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 17.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.28 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 2.67 Bn |
| Sep 30, 2025 | 714.00 Mn |
| Jun 30, 2025 | 1.55 Bn |
| Mar 31, 2025 | 1.66 Bn |
| Dec 31, 2024 | -2.27 Bn |
| Sep 30, 2024 | 2.08 Bn |
| Jun 30, 2024 | 2.15 Bn |
| Mar 31, 2024 | 1.76 Bn |
| Dec 31, 2023 | 1.21 Bn |
| Sep 30, 2023 | 1.95 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Mar 31, 2023 | 475.00 Mn |
| Dec 31, 2022 | 2.97 Bn |
| Sep 30, 2022 | 4.40 Bn |
| Jun 30, 2022 | 1.18 Bn |
| Mar 31, 2022 | 4.93 Bn |
| Dec 31, 2021 | 4.27 Bn |
| Sep 30, 2021 | 3.69 Bn |